Fusion Pharmaceuticals Inc. Other Income and Expense
Fusion Pharmaceuticals Inc. reported Other Income and Expense of $1.95 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for the quarter ending 2024-03-31 was $1.95M, a 253.16% increase year-over-year.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for the quarter ending 2023-12-31 was $1.39M.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for the quarter ending 2023-09-30 was $1.88M.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for the quarter ending 2023-06-30 was $1.29M.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for fiscal 2023 was $5.12M.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for fiscal 2022 was -$1.42M, a 266.47% decline from fiscal 2021.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for fiscal 2021 was $850.00K.
- Fusion Pharmaceuticals Inc. nonoperating income (expense) for fiscal 2020 was -$37.79M, a 1755.87% decline from fiscal 2019.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.95M 10-Q · filed 2024-05-07 | $3.35M derived: sum of 2 quarters · filed 2024-05-07 | $5.23M derived: sum of 3 quarters · filed 2024-05-07 | $6.52M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $3.28M derived: sum of 2 quarters · filed 2024-03-20 | $4.57M derived: sum of 3 quarters · filed 2024-03-20 | $5.12M 10-K · filed 2024-03-20 |
| 2023-09-30 | $1.88M 10-Q · filed 2023-11-07 | $3.18M derived: sum of 2 quarters · filed 2023-11-07 | $3.73M 10-Q · filed 2023-11-07 | $3.19M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-08 | $1.85M 10-Q · filed 2023-08-08 | $1.31M derived: sum of 3 quarters · filed 2024-05-07 | $337.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $553.00K 10-Q · filed 2024-05-07 | $13.00K derived: sum of 2 quarters · filed 2024-05-07 | -$956.00K derived: sum of 3 quarters · filed 2024-05-07 | -$1.42M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$1.51M derived: sum of 2 quarters · filed 2024-03-20 | -$1.98M derived: sum of 3 quarters · filed 2024-03-20 | -$1.42M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$969.00K 10-Q · filed 2023-11-07 | -$1.44M derived: sum of 2 quarters · filed 2023-11-07 | -$875.00K 10-Q · filed 2023-11-07 | -$731.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$467.00K 10-Q · filed 2023-08-08 | $94.00K 10-Q · filed 2023-08-08 | $238.00K derived: sum of 3 quarters · filed 2023-08-08 | $372.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $561.00K 10-Q · filed 2023-05-11 | $705.00K derived: sum of 2 quarters · filed 2023-05-11 | $839.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.27M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $278.00K derived: sum of 2 quarters · filed 2023-03-16 | $706.00K derived: sum of 3 quarters · filed 2023-03-16 | $850.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $134.00K 10-Q · filed 2022-11-08 | $562.00K derived: sum of 2 quarters · filed 2022-11-08 | $706.00K 10-Q · filed 2022-11-08 | $1.50M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $428.00K 10-Q · filed 2022-08-09 | $572.00K 10-Q · filed 2022-08-09 | $1.37M derived: sum of 3 quarters · filed 2022-08-09 | $1.51M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $144.00K 10-Q · filed 2022-05-10 | $942.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.08M derived: sum of 3 quarters · filed 2022-05-10 | -$36.19M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $939.00K derived: sum of 2 quarters · filed 2022-03-17 | -$36.33M derived: sum of 3 quarters · filed 2022-03-17 | -$37.79M 10-K · filed 2022-03-17 |
| 2020-09-30 | $141.00K 10-Q · filed 2021-11-09 | -$37.13M derived: sum of 2 quarters · filed 2021-11-09 | -$38.59M 10-Q · filed 2021-11-09 | -$40.61M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$37.27M 10-Q · filed 2021-08-10 | -$38.73M 10-Q · filed 2021-08-10 | -$40.75M derived: sum of 3 quarters · filed 2021-08-10 | -$37.01M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$1.46M 10-Q · filed 2021-05-11 | -$3.48M derived: sum of 2 quarters · filed 2021-05-11 | $263.00K derived: sum of 3 quarters · filed 2021-05-11 | $733.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.72M derived: sum of 2 quarters · filed 2021-03-25 | $2.19M derived: sum of 3 quarters · filed 2021-03-25 | $2.28M 10-K · filed 2021-03-25 |
| 2019-09-30 | $3.75M 10-Q · filed 2020-11-10 | $4.22M derived: sum of 2 quarters · filed 2020-11-10 | $4.31M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $470.00K 10-Q · filed 2020-08-11 | $563.00K 10-Q · filed 2020-08-11 |